TD Asset Management »

Cogent Biosciences shares owned by TD Asset Management

Quarter-by-quarter ownership of Cogent Biosciences (COGT) shares owned by TD Asset Management from 13F filings

Historical chart of TD Asset Management investment in Cogent Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Cogent Biosciences held by TD Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cogent Biosciences by TD Asset Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $2.0M 56k 35.52

More positions owned by TD Asset Management

Rbc Cad (RY)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Toronto Dominion Bk Ont Com New (TD)
Bank Of Montreal Cadcom (BMO)
Broadcom (AVGO)
Alphabet Cap Stk Cl A (GOOGL)
Cibc Cad (CM)
Amazon (AMZN)
Meta Platforms Cl A (META)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Enbridge (ENB)
Brookfield Corp Cl A Ltd Vt Sh (BN)
Agnico (AEM)

View all positions for TD Asset Management

Top funds holding Cogent Biosciences

FMR
BlackRock
Vanguard Group
Deerfield Management Company
Fairmount Funds Management
Rtw Investments
Kynam Capital Management
TCG Crossover Management
State Street Corporation
Geode Capital Management
Henderson Group
Balyasny Asset Management
Vivo Capital
Octagon Capital Advisors
Duquesne Family Office

View all funds holding Cogent Biosciences